Cancer News and Research

Latest Cancer News and Research

Raptor Pharmaceutical announces Phase 2b results of DR Cysteamine trial

Raptor Pharmaceutical Corp., today announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis"). The trial, conducted at the University of California, San Diego ("UCSD") General Clinical Research Center, evaluated safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of DR Cysteamine in nine cystinosis patients.

23 Nov 2009

Raptor Pharmaceutical announces results of NGX426 clinical trial

Raptor Pharmaceutical Corp. today announced the presentation of clinical trial data on NGX426, the Company's orally administered, non-opioid, AMPA/kainate receptor antagonist, at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, held on November 20-21 in San Francisco.

23 Nov 2009

Fred Hutchinson Cancer Research Center receives $10 million to advance biomedical research

Fred Hutchinson Cancer Research Center has received a pledge of $10 million to advance the promising field of immunotherapy research to treat and cure cancer, even in late stages.

23 Nov 2009

Initiation of Phase I/IIa clinical trial of IL-7 announced

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of a Phase I/IIa clinical trial of IL-7 in support of tumor lysate/KLH pulsed dendritic cell vaccines in a pilot study of tumor vaccination in patients with metastatic or recurrent pediatric solid tumors and altered T cell homeostasis, including patients with Ewing’s sarcoma family of tumors (ESFT), rhabdomyosarcoma, neuroblastoma, synovial cell sarcoma, desmoplastic small round cell tumor, undifferentiated sarcoma, and embryonal sarcoma.

23 Nov 2009

Medical report showing the devastating impacts of coal on human body released

Physicians for Social Responsibility today released a groundbreaking medical report, "Coal's Assault on Human Health," which takes a new look at the devastating impacts of coal on the human body.

23 Nov 2009

Winship-led team identifies a way to exploit cancer cells' taste for glucose

The pedal-to-the-metal signals driving the growth of several types of cancer cells lead to a common switch governing the use of glucose, researchers at Winship Cancer Institute of Emory University have discovered.

23 Nov 2009

Study examines how dietary restriction and high-caloric diet influence biochemical responses

Researchers at Mount Sinai School of Medicine set out to address a question that has been challenging scientists for years: How do dietary restriction-and the reverse, overconsumption-produce protective effects against aging and disease?

23 Nov 2009

BMI and co-morbidity do not explain racial survival disparity in colon cancer patients

A new study by University of Alabama at Birmingham (UAB) researchers shows that body-mass index (BMI) and co-existing medical conditions (co-morbidity) do not explain the decreased survival observed among African-Americans compared to Caucasians who also have colon cancer. The study is published online Nov. 23 in Cancer, a journal of the American Cancer Society.

23 Nov 2009

Given Imaging introduces new PillCam system at GASTRO 2009 Conference

Given Imaging Ltd., the global leader in capsule endoscopy, today announced the launch of its second-generation PillCam® COLON capsule at the Gastro 2009 Conference taking place in London. Like Given Imaging's other capsule endoscopes, PillCam® SB and PillCam® ESO, PillCam COLON could be a more patient-friendly tool for imaging the gastrointestinal tract.

23 Nov 2009

UK survey reveals the importance of cancer information services

People looking for detailed information about cancer outside of hospitals need a range of different information sources, reveals a Cancer Research UK survey published in the November issue of Cancer Nursing Practice.

23 Nov 2009

Gene deletion can increase common complication of bone marrow transplants

A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Genetics.

23 Nov 2009

New research examines screen time in home-based and center-based child care settings

In a new study, the amount of television viewed by many young children in child care settings doubles the previous estimates of early childhood screen time, with those in home-based settings watching significantly more on average than those in center-based daycares.

23 Nov 2009

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

23 Nov 2009

AARP hosts educational forum to address nation's health care system

With the U.S. House of Representatives passing the landmark Affordable Health Care for America Act (H.R. 3962), and the Senate moving key health reform legislation forward, Congress has taken decisive steps to fix our nation's broken health care system.

23 Nov 2009

Combination therapy improves survival rates of patients with head and neck cancer

Cancer Research UK scientists have found that a combination of chemotherapy and radiotherapy improves survival from advanced head and neck cancer in patients who are not able to have surgery.

23 Nov 2009

Genes from same 'family' interact with each other to prevent skin cancer, says new study

CANCER RESEARCH UK scientists have shown, for the first time, how two genes from the same 'family' can interact with each other to stop cancer in its tracks - according to new findings published in Molecular Cell.

23 Nov 2009

Scientists discover new potential target for treating non-Hodgkin's lymphoma

Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells. By exploiting this mechanism, researchers have been able to powerfully suppress tumor formation in lab testing and in animal models.

22 Nov 2009

Editorial provides guidance for media and journals to help foster healthy skepticism in news coverage

An editorial published online November 20 in the Journal of the National Cancer Institute discusses the exaggerated fears and hopes that often appear in news coverage of cancer research. The editorial provides guidance for both the media and journals to help alleviate the problem.

21 Nov 2009

CPRIT’s cancer research funding awards: 403 proposals still in contention

The Cancer Prevention and Research Institute of Texas (CPRIT) announced today that 403 of the nearly 900 proposals submitted are still in contention for CPRIT’s inaugural cancer research funding awards. The applications for the Individual Investigator Research Award and the High Impact/High Risk Research Award will now undergo a second, more intense peer review evaluation by seven committees over the next six weeks beginning the end of this month.

21 Nov 2009

ENTA opens new medical offices in Edison and Old Bridge

ENT and Allergy Associates LLP (ENTA) is pleased to announce a significant expansion of their practice, with the opening of 2 new locations-in Edison and Old Bridge, New Jersey. These State-of-the-art medical offices will serve the growing population of Middlesex County, with physicians and clinical staff providing full service Otolaryngology, Audiology and Allergy medical services. This expansion includes the merging of Dr. Gerald Scott’s existing Edison and Old Bridge practice into ENTA, effective immediately.

21 Nov 2009